Dermapharm Holding SE or Dermapharm AG, based in Grünwald, is a publicly listed German pharmaceutical company specializing in the manufacture and distribution of dermatological and allergological preparations.
Dermapharm Holding SE or Dermapharm AG, based in Grünwald, is a publicly listed German pharmaceutical company specializing in the manufacture and distribution of dermatological and allergological preparations.
== Company == The company was founded in 1991 by Wilhelm Beier. The company has been based in Grünwald near Munich since 1998. Dermapharm also has sites in Austria, Switzerland, Croatia, Poland and Ukraine as well as in the UK, Italy and Spain. The company manufactures almost all of its products in Germany. With its subsidiary mibe GmbH Arzneimittel, Dermapharm has its own production site in Brehna near Leipzig. The product portfolio mainly consists of generic drugs. After October 2020, the company produced the COVID-19 vaccine tozinameran at the Brenna site on behalf of Biontech. Since the end of April 2021, production of the vaccine started at the subsidiary Allergopharma at the Reinbek site.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).